Xenetic Biosciences Stock Revenue
Xenetic Biosciences fundamentals help investors to digest information that contributes to Xenetic Biosciences' financial success or failures. It also enables traders to predict the movement of Xenetic Stock. The fundamental analysis module provides a way to measure Xenetic Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xenetic Biosciences stock.
Xenetic |
Xenetic Biosciences Company Revenue Analysis
Xenetic Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Xenetic Biosciences Revenue | 2.54 M |
Most of Xenetic Biosciences' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xenetic Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Xenetic Biosciences reported 2.54 M of revenue. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is notably lower than that of the firm.
Xenetic Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xenetic Biosciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xenetic Biosciences could also be used in its relative valuation, which is a method of valuing Xenetic Biosciences by comparing valuation metrics of similar companies.Xenetic Biosciences is currently under evaluation in revenue category among its peers.
Xenetic Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (1.83) % | |||
| Operating Margin | (2.48) % | |||
| Revenue | 2.54 M | |||
| EBITDA | (4.52 M) | |||
| Net Income | (4.13 M) | |||
| Cash And Equivalents | 2.02 M | |||
| Cash Per Share | 2.32 X | |||
| Total Debt | 809.59 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 5.63 X | |||
| Cash Flow From Operations | (4.11 M) | |||
| Beta | 2.3 | |||
| Total Asset | 10.61 M | |||
| Retained Earnings | (193.23 M) | |||
| Working Capital | 8.78 M | |||
| Net Asset | 10.61 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Xenetic Stock
If you are still planning to invest in Xenetic Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xenetic Biosciences' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |